Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06251882
Status:
COMPLETED
Last Update Posted:
2024-02-12
First Post:
2024-02-01
Brief Title:
Efficacy of Ultrasound-guided Injection of 5 Dextrose for Meralgia Paresthesia
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Study Overview
Official Title:
6-month Efficacy of Ultrasound-guided Injection of 5 Dextrose for Meralgia Paresthesia
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Meralgia paresthetica MP is one of the most common peripheral entrapment neuropathies of the lower limbs It is characterized by paresthesia pain tingling numbness hypersensitivity or other abnormal skin sensations on the anterolateral aspect of the thigh The condition results from compression of the lateral femoral cutaneous nerve LFCN along its course often occurring as the nerve exits the pelvisThe injection of 5 dextrose D5W under ultrasound guidance is a novel treatment method for peripheral nerve entrapment However there is limited evidence about the efficacy of this method for patients with MP The investigators found D5W was more safe and effective than corticosteroids for patients with MP Thus this study aimed to evaluate the 6-month efficacy of ultrasound-guided injection of D5W for MP patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None